ADPKD is a systemic disorder characterized by cysts involving multiple organs, cerebral and aortic aneurysms, cardiac valvular abnormalities and renal failure. The genes responsible for the two most common forms of the disease have been identified. The PKD1 genes responsible for the most common forms of the disease have been identified. The PKD1 gene product is a probably membrane glycoprotein thought to mediate cell-cell or cell- matrix interactions. PKD2 is predicted to have 6 transmembrane domains and has modest homology to several types of ion channels. The cellular role of either protein has not yet been elucidated. This proposal brings together the collective expert5ise of investigators from multiple disciplines to tackle the problem in a """"""""Center without walls"""""""". One project is a competitive renewal that aims to identify and characterize binding partners of human PKD1. The PI has shown that the C-terminus of PKD1 can bind to PKD2 and to an unusual Db1 family member of using multiple in vitro and in vivo methods. This proposal seeks to determine the biological relevance of the pr3eviously observed interactions. It also will continue the search for PKD1 binding partners in relevance of the previously observed interactions. It also will continue the search for PKD1 binding partners in fetal murine tissues obtained at a stage when PKD1 protein is known to be essential. Another project will characterize the functions of PKD2 in vivo and in vitro using a model experimental organism, Drosophila melanogaster. The proposed research takes a multi-disciplinary approach to the characterization of the Drosophila homologue of PKD2 using a combination of genetic, electrophysiological, cell biological, biochemical and molecular approaches. In the next project, the power of C. elegans molecular genetics to identify and define pathways of gene action will be applied to PKD function. The PI has found that the C. elegans homologue of PKD1 (LOV1) is essential for normal mating behavior and that the C. elegans homologue of PKD2 co- localizes to the same cell types. He will use this behavioral phenotype to determine the genetic pathways in which these gene products types. He will use this behavioral phenotype to determine the genetic pathways in which these gene products participate. The last project will determine the 3D structures of functionally important domains of PKD1 and PKD2 expressed in their native, non-disease state alone and in complex with each other. The PI of the Pilot and Feasibility has previously found that approximately 25% of vertebrate PKD1 has high homology to the Receptor for Egg Jelly of sea urchin sperm. In the current proposal, he will identify and characterize the sea urchin PKD2.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Specialized Center (P50)
Project #
5P50DK057325-04
Application #
6524248
Study Section
Special Emphasis Panel (ZDK1-GRB-6 (O1))
Program Officer
Moxey-Mims, Marva M
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
4
Fiscal Year
2002
Total Cost
$932,615
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Yu, Hui; Seah, Adeline; Sternberg, Paul W (2010) Re-programming of C. elegans male epidermal precursor fates by Wnt, Hox, and LIN-12/Notch activities. Dev Biol 345:1-11
Garcia-Gonzalez, Miguel A; Outeda, Patricia; Zhou, Qin et al. (2010) Pkd1 and Pkd2 are required for normal placental development. PLoS One 5:
Garcia-Gonzalez, Miguel A; Menezes, Luis F; Piontek, Klaus B et al. (2007) Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway. Hum Mol Genet 16:1940-50
Garcia-Gonzalez, Miguel A; Jones, Jeffrey G; Allen, Susan K et al. (2007) Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease. Mol Genet Metab 92:160-7
Boca, Manila; D'Amato, Lisa; Distefano, Gianfranco et al. (2007) Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta-dependent cell cell mechanical adhesion. Mol Biol Cell 18:4050-61
Kaimori, Aki; Potter, James; Kaimori, Jun-Ya et al. (2007) Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282:22089-101
Boca, Manila; Distefano, Gianfranco; Qian, Feng et al. (2006) Polycystin-1 induces resistance to apoptosis through the phosphatidylinositol 3-kinase/Akt signaling pathway. J Am Soc Nephrol 17:637-47
Stayner, Cherie; Iglesias, Diana M; Goodyer, Paul R et al. (2006) Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease. Hum Mol Genet 15:3520-8
Allen, Erica; Piontek, Klaus B; Garrett-Mayer, Elizabeth et al. (2006) Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors. Hum Mol Genet 15:11-21
Qian, Feng; Wei, Wen; Germino, Gregory et al. (2005) The nanomechanics of polycystin-1 extracellular region. J Biol Chem 280:40723-30

Showing the most recent 10 out of 26 publications